Real-time computing. Real-time news.
March 26, 2007
Golden Helix to Grid-Enable Drug Discovery Software
1 | 2 All »
Golden Helix Inc., a leading provider of genetic analysis and drug discovery software serving most of the world’s largest pharmaceutical companies, announced that it will partner with United Devices to grid-enable Golden Helix’s flagship products, HelixTree and PBAT.
United Devices, which provides secure grid computing solutions to seven of the world’s 10 largest pharmaceutical companies, said the collaboration would be based on its widely adopted Grid MP platform.
Grid computing allows researchers to apply the power of a wide range of an organization’s dedicated and non-dedicated computing resources to run specific applications, such as HelixTree and PBAT, far more quickly and more efficiently. From single cluster management implementations to enterprise application virtualization, Grid MP deployments are proven to increase productivity, efficiency, innovation and performance.
“We are excited to be the first to bring truly high performance computing to the SNP analysis market,” said Josh Forsythe, director of marketing for Golden Helix. “Our customers have voiced concerns over how a lack of computing power limits their ability to perform groundbreaking research. With our new distributed capabilities, analyses that used to take our customers vast amounts of time to perform can now be completed in just minutes.”
HelixTree and PBAT are multi-platform applications that incorporate a comprehensive suite of analysis tools for candidate gene and genome-wide association studies (GWAS). GWAS involve the simultaneous analysis of tens of billions of single nucleotide polymorphisms (SNPs), genetic markers used to discover genes that cause disease and clinical outcomes.
Using traditional single processor computing resources, analysis often could take days or even weeks. However, using HelixTree and PBAT in a grid computing environment, scientists can cut run times to a matter of hours or even minutes by submitting their large, complex analysis jobs in parallel to a wide variety of computing platforms. Using a grid, they maximize distribution and throughput while allowing researchers to make better use of otherwise idle cycles on existing hardware.
“With most of the world’s largest pharmaceutical companies using Golden Helix applications and simultaneously operating grids based on United Devices technology, it makes perfect sense for our two companies to initiate this strategic partnership,” said Alex Lynch, director of strategic alliances at United Devices. “Together we can provide scientists with computing power that will speed their innovation for the benefit of mankind and the success of their respective companies.”
As development efforts are completed, other Golden Helix products will be grid-enabled such as the company’s popular ChemTree software, a drug discovery tool that facilitates intelligent, target specific compound selection for High Throughput Screening (HTS), Golden Helix said.
About Golden Helix, Inc.
Golden Helix is a leading provider of data analysis software products and services designed to accelerate life science research and increase pharmaceutical R&D productivity. Usage of the company’s products have been cited in nearly 100 peer-reviewed articles that detail ground-breaking research to find the genetic and environmental basis of disease and create safer and more effective medicines. Its customers include nine of the top 10 pharmaceutical companies and hundreds of users in the world’s leading biotech, government and academic research organizations. Since 1998, Golden Helix has been committed to Accelerating the Quest for Significance. For more information about Golden Helix and its products, visit its Web site at www.goldenhelix.com.
Page: 1 of 21 | 2 All »
-----
Source: United Devices
Article Tools
Share Options
(Digg, Technorati, more)
